Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05392712

Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

Ultra-sensitive Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
430 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

Magnetocardiography (MCG) is a promising noninvasive and accurate method for detecting myocardial ischemia. Although progress has been made in this area, there is a lack of studies using up-to-date examination instruments for the calibration of MCG analysis. This is a prospective single-center study aiming to build accurate analytical models of MCG to detect coronary lesions and myocardial necrosis. Coronary lesions are measured by coronary angiography (CAG) or coronary CTA, and are defined by both the stenosis degree and the computer-simulated fraction flow reserve. Myocardial necrosis is examined and quantified by cardiac MR. Healthy volunteers, chest pain patients who will receive CAG or CTA examination, and patients with acute myocardial infarction will be enrolled in this study.

Conditions

Interventions

TypeNameDescription
DEVICEMagnetometerinspection equipment for magnetocardiography

Timeline

Start date
2022-05-30
Primary completion
2024-08-30
Completion
2024-12-30
First posted
2022-05-26
Last updated
2024-08-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05392712. Inclusion in this directory is not an endorsement.